Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 493 | 216 | 461 | 463 | 463 |
| Gross Profit | 493 | 216 | 461 | 463 | 463 |
| Operating Expenses | 20,396 | 18,162 | 16,056 | 15,034 | 12,556 |
| Operating Income | -19,903 | -17,946 | -15,595 | -14,571 | -12,093 |
| Other Income | 1,093 | 746 | 806 | 742 | 663 |
| Pre-tax Income | -18,810 | -17,200 | -14,789 | -13,829 | -11,430 |
| Net Income Continuous | -18,810 | -17,200 | -14,789 | -13,829 | -11,430 |
| Net Income | $-18,810 | $-17,200 | $-14,789 | $-13,829 | $-11,430 |
| EPS Basic Total Ops | -3.00 | -3.00 | -3.20 | -3.20 | -2.70 |
| EPS Basic Continuous Ops | -3.02 | -3.00 | -3.19 | -3.19 | -2.66 |
| EPS Diluted Total Ops | -3.00 | -3.00 | -3.20 | -3.20 | -2.70 |
| EPS Diluted Continuous Ops | -3.02 | -3.00 | -3.19 | -3.19 | -2.66 |
| EBITDA(a) | $-19,263 | $-17,487 | $-14,917 | $-13,616 | $-11,553 |